ELISPOT cloning of tumor antigens recognized by cytotoxic T-lymphocytes from a cDNA expression library

Cancer Immunity

Volumn 1, Issue , 2001, Pages 1-10

  Uenaka, Akiko ^a   Hata, Hidenori ^a   Win, Sanda ^a   Ono, Toshiro ^a   Wada, Hisashi ^b   Nakayama, Eiichi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

cDNA library; ELISPOT; Expression cloning; Tumor antigens

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BIOASSAY; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; DNA LIBRARY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GENE EXPRESSION; GENETIC MODEL; LEUKEMIA; MALE; METHODOLOGY; MOLECULAR CLONING; MOUSE; NONHUMAN; PROTEIN ANALYSIS; RECOMBINANT PLASMID; T LYMPHOCYTE;

EID: 3142652004     PISSN: 14249634     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Boon T, Old LJ. Tumor antigens. Curr Opin Immunol 1997; 9: 681-3. (PMID: 9438857)
2. Van den Eynde B, Lethé B, Van Pel A, De Plaen E, Boon T. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J Exp Med 1991; 173: 1373-84. (PMID: 1903428)
3. van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991; 254: 1643-7. (PMID: 1840703)
4. Brichard V, Van Pel A, Wolfel T, Wolfel C, De Plaen E, Lethé B, Coulie P, Boon T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1993; 178: 489-95. (PMID: 8340755)
5. Boon T, Cerottini JC, Van den Eynde B, van der Bruggen P, Van Pel A. Tumor antigens recognized by T-lymphocytes. Ann Rev Immunol 1994; 12: 337-65. (PMID: 8011285)
6. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Sakaguchi K, Appella E, Yannelli JR, Adema GJ, Miki T, Rosenberg SA. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 1994; 91: 6458-62. (PMID: 8022805)
7. Rosenberg SA. A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity 1999; 10: 281-7. (PMID: 10204484)
8. Chaux P, Vantomme V, Stroobant V, Thielemans K, Corthals J, Luiten R, Eggermont AM, Boon T, van der Bruggen P. Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4+ T lymphocytes. J Exp Med 1999; 189: 767-78. (PMID: 10049940)
9. Wang RF, Wang X, Rosenberg SA. Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4+ T cells. J Exp Med 1999; 189: 1659-68. (PMID: 10330445)
10. Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michel H, Sevilir N, Cox AL, Appella E, Engelhard VH. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 1992; 255: 1261-3. (PMID: 1546328)
11. Cox AL, Skipper J, Chen Y, Henderson RA, Darrow TL, Shabanowitz J, Engelhard VH, Hunt DF, Slingluff CL Jr.. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 1994; 264: 716-9. (PMID: 7513441)
12. Rotzschke O, Falk K, Deres K, Schild H, Norda M, Metzger J, Jung G, Rammensee HG. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 1990; 348: 252-4. (PMID: 1700304)
13. Uenaka A, Ono T, Akisawa T, Wada H, Yasuda T, Nakayama E. Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene. J Exp Med 1994; 180: 1599-607. (PMID: 7964448)
14. Fisk B, Blevins TL, Wharton JT, Ioannides CG. Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocytes lines. J Exp Med 1995; 181: 2109-17. (PMID: 7539040)
15. Jager E, Chen YT, Drijfhout JW, Karbach J, Ringhoffer M, Jager D, Arand M, Wada H, Noguchi Y, Stockert E, Old LJ, Knuth A. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med 1998; 187: 265-70. (PMID: 9432985)
16. Gundlach BR, Wiesmuller KH, Junt T, Kienle S, Jung G, Walden P. Determination of T cell epitopes with random peptide libraries. J Immunol Methods 1996; 192: 149-55. (PMID: 8699011)
17. Munz C, Obst R, Osen W, Stevanovic S, Rammensee HG. Alloreactivity as a source of high avidity peptide-specific human CTL. J Immunol 1999; 162: 25-34. (PMID: 9886366)
18. Shastri N. Needles in haystacks: identifying specific peptide antigens for T cells. Curr Opin Immunol 1996; 8: 271-7. (PMID: 8725951)
19. Wada H, Matsuo M, Uenaka A, Shimbara N, Shimizu K, Nakayama E. Rejection antigen peptides on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes: Derivation from the normally untranslated 5′ region of the c-akt proto-oncogene activated by long terminal repeat. Cancer Res 1995; 55: 4780-3. (PMID: 7585504)
20. Czerkinsky C, Andersson G, Ekre HP, Nilsson LA, Klareskog L, Ouchterlony O. Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J Immunol Methods 1988; 110: 29-36. (PMID: 3131436)
21. Hess J, Laumen H, Wirth T. Application of differential cDNA screening techniques to the identification of unique gene expression in tumors and lymphocytes. Curr Opin Immunol 1998; 10: 125-30. (PMID: 9602299)
22. Sahin U, Türeci Ö, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 1995; 92: 11810-3. (PMID: 8524854)
23. Nakayama E, Shiku H, Takahashi T, Oettgen HF, Old LJ. Definition of a unique cell surface antigen of mouse leukemia RL male 1 by cell-mediated cytotoxicity. Proc Natl Acad Sci USA. 1979; 76: 3486-90. (PMID: 91166)
24. Stockert E, DeLeo AB, O'Donnell PV, Obata Y, Old LJ. G(AKSL2): A new cell surface antigen of the mouse related to the dualtropic mink cell focus-inducing class of murine leukemia virus detected by naturally occurring antibody. J Exp Med 1979; 149: 200-15. (PMID: 216764)
25. Nakayama E, Uenaka A, Stockert E, Obata Y. Detection of a unique antigen on radiation leukemia virus-induced leukemia B6RV2. Cancer Res 1984; 44: 5138-44. (PMID: 6091870)
26. DeLeo AB, Shiku H, Takahashi T, John M, Old LJ. Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma. J Exp Med 1977; 146: 720-34. (PMID: 197192)
27. Palladino MA Jr., Srivastava PK, Oettgen HF, DeLeo AB. Expression of a shared tumor-specific antigen by two chemically induced BALB/c sarcomas. Cancer Res 1987; 47: 5704-9. (PMID: 3497717)
28. Potter M. The plasma cell tumors and myeloma protein of mice. In: Busch H, editor. Methods in cancer research. New York (NY): Academic Press; 1967. p. 106-157.
29. Wolfel T, Van Pel A, De Plaen E, Lurquin C, Maryanski JL, Boon T. Immunogenic (tum-) variants obtained by mutagenesis of mouse mastocytoma P815. VIII Detection of stable transfectants expressing a tum- antigen with a cytolytic T cell stimulation assay. Immunogenetics 1987; 26: 178-87. (PMID: 3114137)
30. Dunn TB, Potter M. A transplantable mast-cell neoplasm in the mouse. J Natl Cancer Inst 1957; 18: 587-601.
31. Dialynas DP, Quan ZS, Wall KA, Pierres A, Quintans J, Loken MR, Pierres M, Fitch FW. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immnol 1983; 131: 2445-51. (PMID: 6415170)
32. Ozato K, Hansen TH, Sachs DH. Monoclonal antibodies to mouse MHC antigens. II. Antibodies to the H-2Ld antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex. J Immunol 1980; 125: 2473-7. (PMID: 7191868)
33. Havell EA. Purification and further characterization of an anti-murine interferon-gamma monoclonal neutralizing antibody. J Interfern Res 1986; 6: 489-97. (PMID: 3100664)
34. Udaka K, Tsomides TJ, Eisen HN. A naturally occuring peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein. Cell 1992; 69: 989-98. (PMID: 1606619)
35. Lurquin C, Van Pel A, Mariame B, De Plaen E, Szikora JP, Janssens C, Reddehase MJ, Lejeune J, Boon T. Structure of the gene of tum-transplantation antigen P91A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells. Cell 1989; 58: 293-303. (PMID: 2568889)
36. Atherton E, Logan CJ, Sheppard RC. Peptide synthesis. Part2. Procedures for solid phase synthesis using Na-fluorenylmethoxycarbamylamino-acid on polyamide supports. Synthesis of substance P and of acyl carrier protein 65-74 decapeptide. J Chem Soc Lond Perkin Trans 1981; 1: 538-43.
37. Yokoi T, Uenaka A, Ono T, Onizuka S, Inoue H, Nakayama E. Diversity of epitopes recognized by cytotoxic T lymphocytes that are specific for rejection antigen peptide pRL1a presented on BALB/c leukemia RL Male 1. Int Immunol 1997; 9: 1195-201. (PMID: 9263017)
38. Dailey L, Basilico C. Sequences in the polyomavirus DNA regulatory region involved in viral DNA replication and early gene expression. J Virol 1985; 54: 739-49. (PMID: 2987528)